http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0014425-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d709e3167fa2f99a1803c9cfeb0aca63
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-252
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
filingDate 1980-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d3476c813deb870a3bca47f115c6c68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10606eccc71bb17a9da670709d24e298
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f8599a12a3c481436829260b582ad49
publicationDate 1980-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0014425-A1
titleOfInvention Anthracycline glycosides, methods for the production thereof and therapeutical compositions containing same
abstract Compounds which in form of pharmaceutical preparations have an antitumor activity higher or comparable to those of conventional drugs, e.g. Daunorubicin and Doxorubicin. The compounds are of the formulan wherein one of R 1 and R 2 represents a hydrogen atom, the other of R, and R 2 represents a formyl, hydroxymethyl or aminomethyl group, and R 3 represents a hydrogen atom or a hydroxy or acyloxy group, and pharmaceutically acceptable acid addition salts of such compounds in which one of R 1 and R 2 represents an aminomethyl group, methods for preparation of said compounds and therapeutical compositions containing same.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0051279-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2187891-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2636411-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2660561-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BE-1000407-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2605321-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8802830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8357785-B2
priorityDate 1979-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1091448-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID425307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226431980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129266663
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226431981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15930782
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2763134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135935977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12656815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128446950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703

Total number of triples: 43.